Provided the association between higher CAV1 and BRCA1 deficiency or basal phenotype [18,19,47], that are both risk factors for contralateral breast cancer [49], cytoplasmic CAV1 may be a proxy marker for these factors, representing a tumor phenotype that tends to occur in the contralateral breast. This evidence concerns the gene CAV1 and neoplasm.